Background—Cardiac resynchronization therapy with defibrillator (CRT-D) reduces
morbidity and mortality among selected patients with heart failure in clinical trials. The …

Abstract Background The Resynchronization–Defibrillation for Ambulatory Heart Failure
Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients …

PURPOSE: Cardiac resynchronization therapy with implantable cardioverter defibrillator
(CRT-D) has been shown to improve symptoms in patients with chronic heart failure (CHF) …

Background—Cardiac resynchronization therapy (CRT) alone or combined with an
implantable defibrillator (CRT-D) has been shown to improve exercise capacity and quality …

Aims Cardiac resynchronization therapy (CRT) with or without a defibrillator reduces
morbidity and mortality in selected patients with heart failure (HF) but response can be …

Aims Cardiac resynchronization therapy (CRT) for chronic heart failure with left ventricular
systolic dysfunction (LVSD) consistently improves survival against optimal medical therapy …

The prevalence of heart failure (HF) has been steadily increasing. In 2006 there were
approximately 5.8 million people with HF in the United States, 1 and an estimated 23 million …

Objectives: The purpose of this study was to perform a systematic review and meta-analysis
of prospective randomized clinical trials of cardiac resynchronization therapy (CRT) versus …

Background Studies of cardiac resynchronization therapy in addition to an implantable
cardioverter defibrillator in patients with mild to moderate congestive heart failure had not …

Objectives: We attempted to assess the efficacy of combined cardiac resynchronization
therapy-implantable cardioverter-defibrillator (CRT-ICD) in heart failure patients with and …